Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
NEWSLETTER  |  PRINT VERSION
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine > Obituaries > Giorgio Parmiani: Cancer immunology looses a mentor and a pioneer
  • Obituaries

Giorgio Parmiani: Cancer immunology looses a mentor and a pioneer

  • 24 March 2021
  • Adriana Albini
Giorgio Parmiani: Cancer immunology looses a mentor and a pioneer
Total
8
Shares
8
0
0
0
0

I am writing a note in tribute to one of our oncology research leaders, who has just left us: Giorgio Parmiani – a pioneer in immunology. The scientific community mourns him.

Parmiani was internationally recognised in the field of tumour immunology and immunotherapy. He was among the first to describe the immune response against differentiation antigens in melanoma patients and to molecularly characterise them.

In collaboration with other researchers, he promoted clinical and translational studies of anti-cancer vaccination in patients with metastatic melanoma and colon and prostate cancers, and was principal investigator of numerous clinical-translational protocols in onco-immunology. He authored/co-authored around 500 articles and more than 30 book chapters, which have been cited more than 10,000 times in recent years.

Parmiani was born in 1938 in Sesto San Giovanni, north of Milan, and he studied medicine at Milan University, graduating in 1964. He spent his early career at Milan’s National Cancer Institute, where he was appointed Head of the Experimental and Clinical Research Unit, Director of Cancer Immunotherapy and subsequently Director of the Department of Innovative Therapies, as well as General Manager. In 2007 he moved to Milan’s San Raffaele Hospital, where for ten years he was Director of the Immuno-Biotherapy Unit of the Molecular Oncology Division.

As an adjunct Professor, he taught Immunology at the University of Brescia, and Oncology at the Life and Health University of San Raffaele. He also established and headed up the PhD course in Molecular Oncology run at the National Cancer Institute in conjunction with the Open University (UK). Over the course of his career he worked and taught in universities in the United States, France, England and Italy. He was a passionate professor and a challenging partner in scientific discussions, and many of his students went on to distinguish themselves internationally.

Parmiani was a member of various national and international research associations, and served as President of the Italian Cancer Society (http://www.cancerologia.it/). He founded the Italian Network for Cancer Biotherapy and Immunotherapy (NIBIT) in 2004, serving as its first President.

His great scientific work earned him numerous awards, including the 2008 Richard V. Smalley, MD Memorial Award, given by the Society for Immunotherapy of Cancer.

Parmiani was also very involved in civic life. In 1987 he was appointed Deputy Mayor and Assessor (City Councillor) for social services and sport in his home town, Sesto San Giovanni. He continued to be active in the political and cultural life of the city, and for many years organised a Science Club in collaboration with the Sesto San Giovanni Civic Library.

A generous and sincere person in all circumstances, Giorgio was a scholar, a mentor, a worker, with great passion for politics, sport and for his many professional commitments.  He was a charismatic figure in immunology and a great medical personality and a gentleman, who will be sorely missed by us all.

He leaves his loving wife Itala Cosmo and daughters Lara and Lisa.

The importance of a scientist as a leader is fundamental for the moral and psychological support of the community. Giorgio Parmiani was a special one.

Total
8
Shares
Share 8
Tweet 0
Share 0
Share 0
Share 0
Adriana Albini

Previous Article
  • News

HPV vaccine “lying around” unused in Africa due to pandemic disruption

  • 19 March 2021
  • Esther Nakkazi
View Post
Next Article
  • Articles
  • Medicine

Can gene therapy be made to work against solid tumours?

  • 25 March 2021
  • Rachel Brazil
View Post
You May Also Like
View Post
  • Obituaries

Louis Denis: one of urology’s most influential and patient-facing physicians

  • Simon Crompton
  • 30 August 2021
View Post
  • Obituaries

Michael Peckham – the artist-oncologist who helped shape our world

  • Anna Wagstaff
  • 23 August 2021
View Post
  • Obituaries

In memoriam Louis Denis

  • Editorial Staff
  • 11 August 2021
View Post
  • Obituaries

Bella Kaufman: a rare combination of humanity and morality

  • Anna Wagstaff
  • 24 June 2021
View Post
  • Obituaries

Angelo Di Leo leaves a living legacy of quality care and research excellence

  • Anna Wagstaff
  • 14 June 2021
View Post
  • Obituaries

José Baselga: A giant of medical oncology

  • Marc Beishon
  • 26 March 2021
View Post
  • Obituaries

Gordon McVie 1945–2021: a lifetime dedicated to defeating cancer

  • Adriana Albini
  • 22 January 2021
View Post
  • Obituaries

In memoriam: Alfredo Die Goyanes, oncology surgeon

  • Augusto García Villanueva
  • 9 November 2020

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

search
or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • Multicomponent prevention strategy reduces risk of cancer
    • 20 May 2022
  • Lumpectomy as effective as mastectomy in young breast cancer patients
    • 13 May 2022
  • Multi organ chip could facilitate personalised cancer therapy 
    • 12 May 2022
  • 100,000 Genomes Project pinpoints new cancer genetic culprits
    • 29 April 2022
  • IL-6 provides missing link between exercise and colon cancer protection
    • 28 April 2022
Article
  • What can we expect from mRNA cancer vaccines?
    • 13 May 2022
  • Sri Lanka cancer care hit by foreign currency crisis
    • 6 May 2022
  • From social determinants to cancer outcomes: the cell biology behind the disparities
    • 29 April 2022
Latest printed issue
Social

Would you follow us ?

Contents
  • Message from a Ukrainian oncologist: Please prioritise my patients ‒ if you don’t who will?
    • 19 April 2022
  • Pandemics, War, Reconstruction and the Duty of Medicine and Science
    • 4 April 2022
  • Crisis in the Ukraine: we can help by doing what we do best
    • 4 March 2022
MENU
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine
  • About the Magazine
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is funded by SPCC Sharing Progress in Cancer Care | Piazza Indipendenza 2, 6500 Bellinzona - Switzerland | info@spcc.net

Archivio Cancerworld

Input your search keywords and press Enter.